U-Neuron Biomedical

U-Neuron Biomedical Enterprise Value

The Enterprise Value (EV) of U-Neuron Biomedical (6973.TWO) as of Oct 16, 2026 is 794.59 M TWD. In the previous year, Enterprise Value (EV) was 1.07 B TWD — a change of -25.89% (lower).

Enterprise Value

794.59 MTWD

YoY

-25.89%

Last updated:

Enterprise Value (EV) of U-Neuron Biomedical is 2024 794.59 M TWD. Enterprise Value (EV) of U-Neuron Biomedical was 2023 1.07 B TWD. It decreases by -25.89% lower compared to the previous year.

The U-Neuron Biomedical Enterprise Value history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Enterprise Value
Date
Enterprise Value
Jan 1, 2021
1.34 B TWD
Jan 1, 2022
1.38 B TWD
Jan 1, 2023
1.07 B TWD
Jan 1, 2024
794.59 M TWD
The U-Neuron Biomedical Enterprise Value history
YEAREnterprise ValueYoY
794.59 MTWD-25.89%
1.07 BTWD-22.30%
1.38 BTWD+2.83%
1.34 BTWD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

U-Neuron Biomedical Stock analysis

What does U-Neuron Biomedical do? U-Neuron Biomedical Inc, headquartered in Taipei, Taiwan, operates in the Health Care sector within the Biotechnology industry. The company, listed on 20 July 2023, develops cosmetics, health care consumer products, and new drugs. Its drug development focuses on allogeneic amniotic fluid stem cells for applications like erectile dysfunction (UA002) and dry eye (UB003). Cosmetic products, featuring deer amniotic fluid stem cell derivatives, include anti-aging masks, essences, and creams for repair and hydration, primarily sold domestically in Taiwan. U-Neuron Biomedical is one of the most popular companies on Eulerpool.

Frequently Asked Questions about U-Neuron Biomedical stock

Enterprise Value (EV) of U-Neuron Biomedical is 794.59 M TWD in 2024.

Enterprise Value (EV) of U-Neuron Biomedical changed from 1.07 B TWD to 794.59 M TWD, representing a -25.89% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Enterprise Value (EV) U-Neuron Biomedical since 2006 – with annual values, charts, and detailed analysis.

Enterprise Value represents the total value of a company, including both equity and debt, minus cash. It provides a more comprehensive picture than market capitalization alone.

EV = Market Capitalization + Total Debt - Cash & Equivalents

To evaluate Enterprise Value (EV)'s TWD, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Enterprise Value (EV).

A 'good' TWD varies by industry and company stage. On Eulerpool, you can compare Enterprise Value (EV)'s U-Neuron Biomedical with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Valuation — U-Neuron Biomedical

P/EP/SEV/EBITP/BP/CFP/FCFPEGEV/RevenueEV/EBITDAEV/FCFEarnings YieldFCF YieldMarket capitalizationEnterprise ValueForward P/EP/TBVShareholder YieldBuyback YieldDiv.-Adj. PEGEV/OCF

All Key Metrics — U-Neuron Biomedical